Literature DB >> 24166221

How well do various health outcome definitions identify appropriate cases in observational studies?

Richard A Hansen1, Michael D Gray, Brent I Fox, Joshua C Hollingsworth, Juan Gao, Peng Zeng.   

Abstract

BACKGROUND: Observational data can be useful for drug safety research, but accurate measurement of adverse health outcomes is paramount. Best practices for identifying important health outcomes of interest (HOI) are needed.
OBJECTIVES: To evaluate the extent to which health outcome definitions commonly used in observational database studies identify cases that are consistent with expert panel assessment of the underlying data.
METHODS: Competing HOI definitions were used to identify potential cases of acute liver injury (ALI; n = 208), acute kidney injury (AKI; n = 200), and myocardial infarction (MI; n = 204) in the Truven MarketScan Lab Database (MSLR). Panelists reviewed patient-level data and answered questions about whether they believed the case actually reflected the HOI and their certainty of case classification on a 10-point scale (1 = unlikely to 10 = likely). Each patient was reviewed independently by two panelists. Case disagreements were resolved through consensus meetings. Positive predictive value (PPV) was calculated as the number of cases deemed to be true over the total number of sampled cases. Kappa statistics assessed inter-rater agreement.
RESULTS: PPV ranged from 0 to 52 % across ALI definitions, 12 to 82 % across AKI definitions, and 1 to 56 % across MI definitions. Certainty scores on the 10-point scale paralleled the PPV, with a range of mean values from 1.7 to 4.8 across ALI definitions, 3.1 to 6.0 across AKI definitions, and 2.8 to 5.7 across MI definitions. Inter-rater agreement was low to moderate (Kappa range 0.0-0.6). IMPLICATIONS/
CONCLUSIONS: Existing HOI definitions had relatively low PPV based on expert panel review. Experts commonly disagreed on case classification. Additional work is needed to refine HOI case definitions if observational data are to be reliably used for health outcome assessment.

Entities:  

Mesh:

Year:  2013        PMID: 24166221     DOI: 10.1007/s40264-013-0104-0

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  8 in total

1.  Validation of a common data model for active safety surveillance research.

Authors:  J Marc Overhage; Patrick B Ryan; Christian G Reich; Abraham G Hartzema; Paul E Stang
Journal:  J Am Med Inform Assoc       Date:  2011-10-28       Impact factor: 4.497

2.  Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.

Authors:  Paul E Stang; Patrick B Ryan; Judith A Racoosin; J Marc Overhage; Abraham G Hartzema; Christian Reich; Emily Welebob; Thomas Scarnecchia; Janet Woodcock
Journal:  Ann Intern Med       Date:  2010-11-02       Impact factor: 25.391

Review 3.  Validity of administrative database coding for kidney disease: a systematic review.

Authors:  Meghan E O Vlasschaert; Shayna A D Bejaimal; Daniel G Hackam; Robert Quinn; Meaghan S Cuerden; Matthew J Oliver; Arthur Iansavichus; Nabil Sultan; Alison Mills; Amit X Garg
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

4.  Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury.

Authors:  Kartik Jinjuvadia; Wendy Kwan; Robert J Fontana
Journal:  Am J Gastroenterol       Date:  2007-07-27       Impact factor: 10.864

5.  Developing an expert panel process to refine health outcome definitions in observational data.

Authors:  Brent I Fox; Joshua C Hollingsworth; Michael D Gray; Michael L Hollingsworth; Juan Gao; Richard A Hansen
Journal:  J Biomed Inform       Date:  2013-06-13       Impact factor: 6.317

6.  Investigation of relation between use of oral contraceptives and thromboembolic disease.

Authors:  M P Vessey; R Doll
Journal:  Br Med J       Date:  1968-04-27

7.  Assessment of case definitions for identifying acute liver injury in large observational databases.

Authors:  Aaron J Katz; Patrick B Ryan; Judith A Racoosin; Paul E Stang
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

8.  Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates.

Authors:  Amy Metcalfe; Annabelle Neudam; Samantha Forde; Mingfu Liu; Saskia Drosler; Hude Quan; Nathalie Jetté
Journal:  Health Serv Res       Date:  2012-06-28       Impact factor: 3.402

  8 in total
  8 in total

Review 1.  Desideratum for evidence based epidemiology.

Authors:  J Marc Overhage; Patrick B Ryan; Martijn J Schuemie; Paul E Stang
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

2.  Comment on: "Desideratum for evidence-based epidemiology".

Authors:  Sean Hennessy; Charles E Leonard
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

3.  From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data.

Authors:  Vassilis Koutkias
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

Review 4.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

5.  Computational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworks.

Authors:  Vassilis G Koutkias; Marie-Christine Jaulent
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

6.  Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies.

Authors:  Rosa Gini; Martijn Schuemie; Jeffrey Brown; Patrick Ryan; Edoardo Vacchi; Massimo Coppola; Walter Cazzola; Preciosa Coloma; Roberto Berni; Gayo Diallo; José Luis Oliveira; Paul Avillach; Gianluca Trifirò; Peter Rijnbeek; Mariadonata Bellentani; Johan van Der Lei; Niek Klazinga; Miriam Sturkenboom
Journal:  EGEMS (Wash DC)       Date:  2016-02-08

7.  Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study.

Authors:  Ha Il Kim; Seo Young Park; Hyun Phil Shin
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

Review 8.  Translational Biomedical Informatics and Pharmacometrics Approaches in the Drug Interactions Research.

Authors:  Pengyue Zhang; Heng-Yi Wu; Chien-Wei Chiang; Lei Wang; Samar Binkheder; Xueying Wang; Donglin Zeng; Sara K Quinney; Lang Li
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.